Discussion paper DP18025 Vaccine Progress, Stock Prices, and the Value of Ending the Pandemic Viral Acharya Timothy Johnson Suresh Sundaresan Steven Zheng 26 Mar 2023 Asset Pricing D6 D8 E21 Q54
VoxEU Column The impact of Fox News on the US COVID-19 vaccination campaign Léo Picard Matteo Pinna Christoph Goessmann 15 Apr 2022 COVID-19
Discussion paper DP16728 International Evidence on Vaccines and the Mortality to Infections Ratio in the Pre-Omicron Era Joshua Aizenman Alex Cukierman Yothin Jinjarak Weining Xin 23 Feb 2022 International Macroeconomics and Finance Public Economics I18 I12 H41 H51 C21 C22 D7
VoxEU Column Monetary incentives increase COVID-19 vaccinations, nudges do not Erik Wengström Friedrich Schneider Devin G. Pope Stephan Meier Armando N. Meier Pol Campos-Mercade 19 Nov 2021 COVID-19
VoxEU Column Patent buyouts can help win the race against coronavirus mutations Michael Stolpe 23 Sep 2021 COVID-19 Industrial organisation
Discussion paper DP16428 How COVID-19 vaccine supply chains emerged in the midst of a pandemic Chad Bown Thomas Bollyky 7 Aug 2021 International Trade and Regional Economics F13
Discussion paper DP16372 How many lives could be saved through the early sharing of vaccines globally? Mehdi Benatiya Andaloussi Antonio Spilimbergo 19 Jul 2021 Development Economics International Trade and Regional Economics Public Economics
VoxEU Column Vaccines for developing countries: Views of leading economists on patent waivers and vaccinating the world Romesh Vaitilingam 22 May 2021 COVID-19 Productivity and Innovation
Discussion paper DP15800 Whom to Vaccinate First - Some Important Trade-offs Rikard Forslid Mathias Herzing 11 Feb 2021 Public Economics
VoxEU Column We have built them, and people will come: A ‘bottom-up’ approach for COVID-19 vaccines Baldeep K. Dhaliwal Anita Shet David Bloom 8 Jan 2021 Health Economics COVID-19
VoxEU Column Public preferences for prioritising a COVID-19 vaccine Jeroen Luyten Sandy Tubeuf Roselinde Kessels 25 Nov 2020 COVID-19
